CIDRAP newsletters options
The initial COVID-19 vaccine campaign in the United States was associated with fewer infections, emergency department (ED) visits, and hospitalizations among adults 65 and older, finds a study yesterday in The Lancet.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
The high protection was found even amid high Alpha and Delta variant circulation.
Covaxin, made by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart.
COVID-19 didn't appear to spread efficiently within and among teams last fall.
"Please know we have conducted a thorough review of the safety data."
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
The ACIP recommendation now goes to CDC head Walensky for final approval.
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
A hybrid of natural and vaccine immunity may protect better against breakthrough infections.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
Among children with community-acquired pneumonia (CAP) who were discharged from the hospital within 48 hours but required further outpatient treatment, a lower dose of oral amoxicillin was non-inferior to a higher dose, and a 3-day duration was non-inferior to 7 days, according to the results of a randomized clinical trial published today in JAMA.
"As we await CDC's decision, we are not waiting on operations or logistics."
The group agreed on a goal of vaccinating at least 70% of the world's population by the middle of next year.
A pair of values-based incentive programs at US hospitals were linked to a decline in C difficile.
Antibiotic prescribing during the early COVID-19 months in Canada dropped sharply, according to two new studies, one that looked at retail pharmacy trends across the country and one that focused on outpatient prescribing patterns in Ontario.
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
The secondary attack rate was 25% in fully vaccinated people and 38% in the unvaccinated.
The authors say all eligible people should get the vaccine ASAP, including those previously infected.
The acting FDA chief says the move will bring us closer to a sense of normalcy.
